(Q41100709)

26 September 2017

title

Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. (English)

1 reference

26 September 2017

1 reference

Hamman MA

1

1 reference

26 September 2017

Thompson GA

series ordinal

2

1 reference

26 September 2017

Hall SD

series ordinal

3

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

26 September 2017

published in

Biochemical Pharmacology

1 reference

26 September 2017

volume

54

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

33-41

1 reference

The metabolism of ibuprofen

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (—)-isomer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

The contribution of cytochrome P450-dependent arachidonate metabolites to integrated renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

In vitro methods for assessing human hepatic drug metabolism: their use in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Studies of urinary metabolites of 2-(4-isobutylphenyl) propionic acid by gas-liquid chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Determination of the cytochrome P-450 IV marker, ω-hydroxylauric acid, by high-performance liquid chromatography and fluorimetric detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Isomeric inversion of ibuprofen (R)-enantiomer in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Stereoselective disposition of ibuprofen enantiomers in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Renal toxicity of the nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Renal syndromes associated with nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900143-3

10.1016/S0006-2952(97)00143-3

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference